Mechanistic description
PINK1/PARKIN-mediated mitophagy is impaired in sporadic PD due to upstream mitochondrial stress. Enhancing parkin translocation or inhibiting USP30 (deubiquitinase opposing mitophagy) can restore clearance of damaged mitochondria. This hypothesis extrapolates from familial PD (PINK1/PARKIN mutations) to sporadic disease without direct evidence of shared mechanism. USP30 inhibitors showed promising preclinical neuroprotection but have not translated to clinical success. The fundamental problem is the Familial-to-Sporadic Gap—assuming identical mechanisms in genetic vs. idiopathic PD lacks validation. Multiple compensatory mitophagy pathways (FUNDC1, BNIP3) may limit therapeutic potential. The hypothesis received the most severe confidence reduction from the Skeptic (0.62), reflecting failed clinical translation despite strong preclinical data.
Mechanism / pathway
- USP30
- neurodegeneration
Evidence for (3)
PINK1/PARKIN mitophagy pathway well-characterized; PMID 25695307
USP30 inhibitors enhance mitophagy in cellular models; PMID 29251730
In vivo mitophagy reporters developed (mito-QC); PMID related
Evidence against (4)
No direct evidence that sporadic PD involves same mitophagy impairment as familial PINK1/PARKIN cases
Despite strong preclinical data, no mitophagy-enhancing therapy has succeeded in PD clinical trials
Cells upregulate alternative mitophagy pathways (FUNDC1, BNIP3) when PINK1/PARKIN impaired
Excessive mitophagy can be detrimental—therapeutic window undefined
Evidence matrix
Supporting
- PINK1/PARKIN mitophagy pathway well-characterized; PMID 25695307 PMID:25695307
- USP30 inhibitors enhance mitophagy in cellular models; PMID 29251730 PMID:29251730
- In vivo mitophagy reporters developed (mito-QC); PMID related
Contradicting
- No direct evidence that sporadic PD involves same mitophagy impairment as familial PINK1/PARKIN cases
- Despite strong preclinical data, no mitophagy-enhancing therapy has succeeded in PD clinical trials
- Cells upregulate alternative mitophagy pathways (FUNDC1, BNIP3) when PINK1/PARKIN impaired
- Excessive mitophagy can be detrimental—therapeutic window undefined
Bayesian persona consensus
scidex.consensus.bayesian compounds vote / rank / fund signals
from 1 contributing personas in log-odds space, weighted
by uniform. Prior 50%.
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). Mitophagy Induction as Neuroprotective Strategy in Sporadic Parkinson's Disease. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-89be8460d0
@misc{scidex_hypothesis_h89be846,
title = {Mitophagy Induction as Neuroprotective Strategy in Sporadic Parkinson's Disease},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-89be8460d0},
note = {SciDEX artifact hypothesis:h-89be8460d0}
}